Personalized Oxygen Therapy Systems for Cancer Treatment

A next-generation oxygen therapeutic system that leverages machine learning, non-invasive imaging, and wearable devices to provide personalized oxygen therapy for cancer patients, enhancing treatment outcomes and improving patient care.

The original patent disclosed the use of oxygen therapeutics in combination with chemotherapy and radiation therapy. However, this approach had limitations, including the inability to provide customized oxygen doses and real-time tumor oxygenation feedback. The new inventive concept addresses these limitations by integrating machine learning, non-invasive imaging, and wearable devices to provide personalized oxygen therapy.

The inventive concept comprises a system for personalized oxygen therapy in cancer treatment, which includes a machine learning-based predictive model for determining optimal oxygen levels in individual patients. The system also features an oxygen therapeutic delivery system adapted to provide customized oxygen doses based on the predictive model. Additionally, the system may incorporate a non-invasive imaging system for real-time tumor oxygenation feedback and a wearable device for continuous oxygen monitoring and personalized oxygen therapy. The system may also integrate with immunotherapy agents and predictive models for determining optimal oxygen levels and immunotherapy dosing regimens.

The new claims introduce the use of machine learning, non-invasive imaging, and wearable devices to provide personalized oxygen therapy, which is a significant departure from the original patent's approach. The integration of these technologies enables real-time tumor oxygenation feedback, customized oxygen doses, and improved treatment outcomes, making the new inventive concept novel and non-obvious.

Alternative embodiments of the inventive concept may include the use of different machine learning algorithms, various types of non-invasive imaging systems, and different wearable device designs. Additionally, the system may be adapted for use in different types of cancer treatment, such as radiation therapy or chemotherapy.

The inventive concept has significant commercial potential in the cancer treatment market, particularly in the areas of personalized medicine and precision oncology. The system's ability to provide customized oxygen therapy and improve treatment outcomes could lead to increased adoption and revenue growth in the market.